Rank | Gene Set | Z-score |
---|---|---|
1 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 7.73068658 |
2 | sarcomere organization (GO:0045214) | 5.87589659 |
3 | intestinal cholesterol absorption (GO:0030299) | 5.78322696 |
4 | tricarboxylic acid cycle (GO:0006099) | 5.28168880 |
5 | * ventricular cardiac muscle cell action potential (GO:0086005) | 5.16484459 |
6 | transcytosis (GO:0045056) | 5.09596104 |
7 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 5.06069939 |
8 | intestinal absorption (GO:0050892) | 5.05759504 |
9 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 4.77748868 |
10 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.70347992 |
11 | cardiac myofibril assembly (GO:0055003) | 4.67300823 |
12 | NADH metabolic process (GO:0006734) | 4.65240452 |
13 | neutrophil activation involved in immune response (GO:0002283) | 4.63757970 |
14 | negative regulation of cell killing (GO:0031342) | 4.56858118 |
15 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.56858118 |
16 | ATP synthesis coupled proton transport (GO:0015986) | 4.55086167 |
17 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.55086167 |
18 | response to peptidoglycan (GO:0032494) | 4.51327849 |
19 | respiratory electron transport chain (GO:0022904) | 4.47351447 |
20 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.44901586 |
21 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.44728138 |
22 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.44728138 |
23 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.44728138 |
24 | modulation by symbiont of host immune response (GO:0052553) | 4.44728138 |
25 | positive regulation by symbiont of host defense response (GO:0052509) | 4.44728138 |
26 | modulation by symbiont of host defense response (GO:0052031) | 4.44728138 |
27 | regulation of cardioblast differentiation (GO:0051890) | 4.44464314 |
28 | electron transport chain (GO:0022900) | 4.35820313 |
29 | macrophage activation involved in immune response (GO:0002281) | 4.33699491 |
30 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.32349000 |
31 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 4.24874027 |
32 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.24636630 |
33 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 4.22236066 |
34 | regulation of actin filament-based movement (GO:1903115) | 4.22174177 |
35 | digestion (GO:0007586) | 4.21206282 |
36 | detection of other organism (GO:0098543) | 4.19774578 |
37 | cell communication involved in cardiac conduction (GO:0086065) | 4.16821060 |
38 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 4.15057488 |
39 | intestinal epithelial cell development (GO:0060576) | 4.09827045 |
40 | myofibril assembly (GO:0030239) | 4.03091905 |
41 | detection of bacterium (GO:0016045) | 4.03087471 |
42 | negative regulation of interleukin-12 production (GO:0032695) | 3.97973990 |
43 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.92732172 |
44 | heart trabecula formation (GO:0060347) | 3.89740661 |
45 | detection of molecule of bacterial origin (GO:0032490) | 3.89169951 |
46 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.85596269 |
47 | immunoglobulin mediated immune response (GO:0016064) | 3.84623405 |
48 | * cardiac muscle contraction (GO:0060048) | 3.82948630 |
49 | regulation of sarcomere organization (GO:0060297) | 3.81808050 |
50 | detection of external biotic stimulus (GO:0098581) | 3.80790417 |
51 | lysine metabolic process (GO:0006553) | 3.80331453 |
52 | lysine catabolic process (GO:0006554) | 3.80331453 |
53 | actomyosin structure organization (GO:0031032) | 3.77818056 |
54 | regulation of respiratory burst (GO:0060263) | 3.76947118 |
55 | cardiac muscle cell development (GO:0055013) | 3.75354148 |
56 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.70289446 |
57 | regulation of skeletal muscle contraction (GO:0014819) | 3.69994097 |
58 | cellular extravasation (GO:0045123) | 3.68650423 |
59 | oxidative phosphorylation (GO:0006119) | 3.66706371 |
60 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.62228807 |
61 | regulation of gamma-delta T cell activation (GO:0046643) | 3.60414691 |
62 | desmosome organization (GO:0002934) | 3.60386590 |
63 | glucocorticoid biosynthetic process (GO:0006704) | 3.59154321 |
64 | regulation of cellular extravasation (GO:0002691) | 3.58860851 |
65 | relaxation of cardiac muscle (GO:0055119) | 3.57867136 |
66 | fatty acid beta-oxidation (GO:0006635) | 3.55723387 |
67 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.54842135 |
68 | cardiac cell development (GO:0055006) | 3.52116797 |
69 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.49178238 |
70 | antibacterial humoral response (GO:0019731) | 3.48821263 |
71 | cytidine metabolic process (GO:0046087) | 3.47192853 |
72 | cytidine catabolic process (GO:0006216) | 3.47192853 |
73 | cytidine deamination (GO:0009972) | 3.47192853 |
74 | regulation of cardiac muscle cell contraction (GO:0086004) | 3.44010595 |
75 | aspartate family amino acid catabolic process (GO:0009068) | 3.43786997 |
76 | carnitine shuttle (GO:0006853) | 3.41460206 |
77 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.40444319 |
78 | detection of biotic stimulus (GO:0009595) | 3.37209427 |
79 | antimicrobial humoral response (GO:0019730) | 3.35092477 |
80 | proline biosynthetic process (GO:0006561) | 3.34355668 |
81 | ethanol metabolic process (GO:0006067) | 3.32156578 |
82 | short-chain fatty acid metabolic process (GO:0046459) | 3.31827850 |
83 | exocrine pancreas development (GO:0031017) | 3.29351875 |
84 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 3.29046065 |
85 | regulation of mast cell degranulation (GO:0043304) | 3.27197053 |
86 | cardiac muscle hypertrophy (GO:0003300) | 3.27176365 |
87 | homocysteine metabolic process (GO:0050667) | 3.27044187 |
88 | cardiac muscle tissue morphogenesis (GO:0055008) | 3.25684498 |
89 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.21461237 |
90 | granulocyte activation (GO:0036230) | 3.19329296 |
91 | response to muramyl dipeptide (GO:0032495) | 3.18464952 |
92 | neutrophil activation (GO:0042119) | 3.17434140 |
93 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.14604071 |
94 | germinal center formation (GO:0002467) | 3.11935128 |
95 | muscle filament sliding (GO:0030049) | 3.09934125 |
96 | actin-myosin filament sliding (GO:0033275) | 3.09934125 |
97 | cellular ketone body metabolic process (GO:0046950) | 3.09112105 |
98 | fatty acid catabolic process (GO:0009062) | 3.08133473 |
99 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.08119879 |
100 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.07738406 |
101 | branched-chain amino acid catabolic process (GO:0009083) | 3.07700231 |
102 | respiratory burst (GO:0045730) | 3.07593368 |
103 | * cardiac conduction (GO:0061337) | 3.07108141 |
104 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.06766271 |
105 | macrophage activation (GO:0042116) | 3.05788184 |
106 | regulation of leukocyte degranulation (GO:0043300) | 3.05702100 |
107 | striated muscle hypertrophy (GO:0014897) | 3.04667071 |
108 | myeloid cell activation involved in immune response (GO:0002275) | 3.04515953 |
109 | 2-oxoglutarate metabolic process (GO:0006103) | 3.04072205 |
110 | * regulation of heart rate by cardiac conduction (GO:0086091) | 3.03840641 |
111 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.03235251 |
112 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.03135717 |
113 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 3.01062411 |
114 | fatty acid transmembrane transport (GO:1902001) | 3.00558519 |
115 | * cardiac muscle cell action potential involved in contraction (GO:0086002) | 3.00225978 |
116 | ATP biosynthetic process (GO:0006754) | 2.99556493 |
117 | regulation of relaxation of muscle (GO:1901077) | 2.98974211 |
118 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.98514745 |
119 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.96987066 |
120 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.96523217 |
121 | regulation of striated muscle contraction (GO:0006942) | 2.95385730 |
122 | actin-mediated cell contraction (GO:0070252) | 2.95298838 |
123 | NIK/NF-kappaB signaling (GO:0038061) | 2.94443197 |
124 | regulation of antigen processing and presentation (GO:0002577) | 2.93677118 |
125 | * cardiac muscle cell action potential (GO:0086001) | 2.93293275 |
126 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.92927860 |
127 | cellular response to type I interferon (GO:0071357) | 2.92917326 |
128 | type I interferon signaling pathway (GO:0060337) | 2.92917326 |
129 | regulation of T cell tolerance induction (GO:0002664) | 2.92565021 |
130 | response to type I interferon (GO:0034340) | 2.92378711 |
131 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.91683615 |
132 | response to host immune response (GO:0052572) | 2.91683615 |
133 | T-helper 1 type immune response (GO:0042088) | 2.90817837 |
134 | muscle tissue morphogenesis (GO:0060415) | 2.90793412 |
135 | positive regulation of antigen processing and presentation (GO:0002579) | 2.90095706 |
136 | leukocyte aggregation (GO:0070486) | 2.89596885 |
137 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.89311916 |
138 | fatty acid oxidation (GO:0019395) | 2.89292437 |
139 | regulation of tolerance induction (GO:0002643) | 2.89181493 |
140 | epithelial cell-cell adhesion (GO:0090136) | 2.88595957 |
141 | atrioventricular valve morphogenesis (GO:0003181) | 2.88564017 |
142 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 2.88456574 |
143 | digestive system process (GO:0022600) | 2.87330354 |
144 | protein retention in ER lumen (GO:0006621) | 2.86122315 |
145 | positive regulation of mast cell activation (GO:0033005) | 2.85289735 |
146 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.84796765 |
147 | succinate metabolic process (GO:0006105) | 2.83976463 |
148 | tricarboxylic acid metabolic process (GO:0072350) | 2.83466615 |
149 | negative regulation of glial cell proliferation (GO:0060253) | 2.83198022 |
150 | defense response to protozoan (GO:0042832) | 2.83197637 |
151 | adult heart development (GO:0007512) | 2.81915711 |
152 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.81625652 |
153 | lipid oxidation (GO:0034440) | 2.80938922 |
154 | biotin metabolic process (GO:0006768) | 2.79804827 |
155 | cobalamin metabolic process (GO:0009235) | 2.79682711 |
156 | branched-chain amino acid metabolic process (GO:0009081) | 2.79268929 |
157 | microglial cell activation (GO:0001774) | 2.79233466 |
158 | B cell mediated immunity (GO:0019724) | 2.78764146 |
159 | mannose metabolic process (GO:0006013) | 2.77907386 |
160 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.76795419 |
161 | * striated muscle contraction (GO:0006941) | 2.75779978 |
162 | amino-acid betaine transport (GO:0015838) | 2.75460157 |
163 | carnitine transport (GO:0015879) | 2.75460157 |
164 | regulation of the force of heart contraction (GO:0002026) | 2.73840586 |
165 | myeloid dendritic cell differentiation (GO:0043011) | 2.72361299 |
166 | regulation of cardiac muscle contraction (GO:0055117) | 2.72096935 |
167 | positive regulation of type 2 immune response (GO:0002830) | 2.70456221 |
168 | carnitine transmembrane transport (GO:1902603) | 2.70328141 |
169 | hemidesmosome assembly (GO:0031581) | 2.69821626 |
170 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.69451260 |
171 | response to host (GO:0075136) | 2.69451260 |
172 | response to host defenses (GO:0052200) | 2.69451260 |
173 | regulation of mast cell activation (GO:0033003) | 2.69375187 |
174 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.66149535 |
175 | response to protozoan (GO:0001562) | 2.65983038 |
176 | response to laminar fluid shear stress (GO:0034616) | 2.64753575 |
177 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.63070226 |
178 | glycosphingolipid catabolic process (GO:0046479) | 2.63028671 |
179 | positive regulation of mast cell degranulation (GO:0043306) | 2.62645823 |
180 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.62645823 |
181 | positive thymic T cell selection (GO:0045059) | 2.62192170 |
182 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.59835820 |
183 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.59064429 |
184 | negative regulation of interleukin-6 production (GO:0032715) | 2.58872669 |
185 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.56443817 |
186 | regulation of type 2 immune response (GO:0002828) | 2.56336606 |
187 | myeloid dendritic cell activation (GO:0001773) | 2.56065932 |
188 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.55136193 |
189 | negative regulation of type 2 immune response (GO:0002829) | 2.52888306 |
190 | dendritic cell chemotaxis (GO:0002407) | 2.50743696 |
191 | peptide catabolic process (GO:0043171) | 2.50304033 |
192 | negative regulation of T cell mediated immunity (GO:0002710) | 2.49799083 |
193 | regulation of regulated secretory pathway (GO:1903305) | 2.49237048 |
194 | positive regulation of B cell differentiation (GO:0045579) | 2.48759025 |
195 | regulation of interferon-alpha production (GO:0032647) | 2.48757139 |
196 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.48407411 |
197 | regulation of podosome assembly (GO:0071801) | 2.47993528 |
198 | positive regulation of tolerance induction (GO:0002645) | 2.46663703 |
199 | glucocorticoid metabolic process (GO:0008211) | 2.46060969 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 7.16461048 |
2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.13506938 |
3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.76774219 |
4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.44182129 |
5 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 3.73378351 |
6 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.58882550 |
7 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.48487944 |
8 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.35741230 |
9 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 3.35207699 |
10 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.09895016 |
11 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.93259927 |
12 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.92899580 |
13 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.89365461 |
14 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.86219918 |
15 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 2.78762101 |
16 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.71568665 |
17 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.62653871 |
18 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.61774170 |
19 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.59276715 |
20 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.58821109 |
21 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.56806590 |
22 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.55791776 |
23 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 2.55235659 |
24 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.54789943 |
25 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.53009160 |
26 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.48109802 |
27 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.43642392 |
28 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.39277367 |
29 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.37840413 |
30 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.37288306 |
31 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.33535629 |
32 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.30515892 |
33 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.21945790 |
34 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.18768847 |
35 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.15914639 |
36 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 2.14721375 |
37 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 2.14721375 |
38 | * SPI1_23127762_ChIP-Seq_K562_Human | 2.14051357 |
39 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 2.13813910 |
40 | * SOX2_20726797_ChIP-Seq_SW620_Human | 2.13313499 |
41 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.11330891 |
42 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.07995965 |
43 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.07537912 |
44 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.05876522 |
45 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.02851356 |
46 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.99559171 |
47 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.99494451 |
48 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.98259897 |
49 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.94647071 |
50 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.94528797 |
51 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.90395109 |
52 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.89269924 |
53 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.85629079 |
54 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.84206930 |
55 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.82876499 |
56 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.80651919 |
57 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.80227729 |
58 | GATA1_22025678_ChIP-Seq_K562_Human | 1.79943236 |
59 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.78627133 |
60 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.78367706 |
61 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.72704037 |
62 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.72565216 |
63 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.72268162 |
64 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.71513705 |
65 | MAF_26560356_Chip-Seq_TH1_Human | 1.71417943 |
66 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.71008941 |
67 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.67816312 |
68 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.66862110 |
69 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.65638764 |
70 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.65196319 |
71 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.63614353 |
72 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.62813766 |
73 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.62294299 |
74 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.62141696 |
75 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.60407345 |
76 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.59048466 |
77 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.58898535 |
78 | MYC_22102868_ChIP-Seq_BL_Human | 1.56971399 |
79 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.55916047 |
80 | ATF3_27146783_Chip-Seq_COLON_Human | 1.55890978 |
81 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.55746212 |
82 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.54980756 |
83 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.52202747 |
84 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.51471681 |
85 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.49638524 |
86 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.47010999 |
87 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.45651413 |
88 | MYB_26560356_Chip-Seq_TH2_Human | 1.45609807 |
89 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.45468869 |
90 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.44791650 |
91 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.41919674 |
92 | GATA1_19941826_ChIP-Seq_K562_Human | 1.39846847 |
93 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.33544392 |
94 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.33164128 |
95 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.32872624 |
96 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.31870923 |
97 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.31089392 |
98 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.29736351 |
99 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.29085591 |
100 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.28761331 |
101 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.28760687 |
102 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.28194006 |
103 | MYB_26560356_Chip-Seq_TH1_Human | 1.28047741 |
104 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.27708305 |
105 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.25527291 |
106 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.24493582 |
107 | * MAF_26560356_Chip-Seq_TH2_Human | 1.23749945 |
108 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.23525619 |
109 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.22974091 |
110 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.21848585 |
111 | * TP63_22573176_ChIP-Seq_HFKS_Human | 1.19579212 |
112 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.19457007 |
113 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.18415493 |
114 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.16273039 |
115 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.16183467 |
116 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16024297 |
117 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.15573221 |
118 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.14937486 |
119 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.14594695 |
120 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.12801034 |
121 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.11792765 |
122 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.11326537 |
123 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.10953029 |
124 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.10489455 |
125 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.10097895 |
126 | KDM2B_26808549_Chip-Seq_K562_Human | 1.09927847 |
127 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.09622241 |
128 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.07971620 |
129 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.07701561 |
130 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.06727173 |
131 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.06721949 |
132 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.06383858 |
133 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.06297101 |
134 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.05234208 |
135 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.04818201 |
136 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.04723558 |
137 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.04131619 |
138 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.02861473 |
139 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.02624346 |
140 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.00771291 |
141 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.99976954 |
142 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.99796589 |
143 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.99413830 |
144 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.99413830 |
145 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.97394058 |
146 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.95790044 |
147 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95752454 |
148 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.95443104 |
149 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.94800009 |
150 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.94387328 |
151 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.92849226 |
152 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.91815504 |
153 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.91183259 |
154 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.90952895 |
155 | P68_20966046_ChIP-Seq_HELA_Human | 0.90681371 |
156 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.90128588 |
157 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.90053070 |
158 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.89962449 |
159 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.89605306 |
160 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.89212672 |
161 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.88609214 |
162 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.88604216 |
163 | CJUN_26792858_Chip-Seq_BT549_Human | 0.88592733 |
164 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.86672945 |
165 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.86285127 |
166 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.84795510 |
167 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.84108652 |
168 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.83073846 |
169 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.81838214 |
170 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.80854740 |
171 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.80741871 |
172 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.80732404 |
173 | GATA2_19941826_ChIP-Seq_K562_Human | 0.78422024 |
174 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.76865597 |
175 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.74901728 |
176 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.74704366 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003303_peritoneal_inflammation | 4.16194863 |
2 | MP0001666_abnormal_nutrient_absorption | 4.08284845 |
3 | MP0002837_dystrophic_cardiac_calcinosis | 4.04359316 |
4 | MP0003724_increased_susceptibility_to | 3.92463046 |
5 | MP0004084_abnormal_cardiac_muscle | 3.73874895 |
6 | MP0003436_decreased_susceptibility_to | 3.69465546 |
7 | MP0004215_abnormal_myocardial_fiber | 3.57701908 |
8 | MP0005083_abnormal_biliary_tract | 3.32411950 |
9 | MP0001835_abnormal_antigen_presentation | 2.99723286 |
10 | MP0005085_abnormal_gallbladder_physiolo | 2.96077959 |
11 | MP0005058_abnormal_lysosome_morphology | 2.94338902 |
12 | MP0005360_urolithiasis | 2.92623903 |
13 | MP0003646_muscle_fatigue | 2.92487252 |
14 | MP0002138_abnormal_hepatobiliary_system | 2.86740639 |
15 | MP0006082_CNS_inflammation | 2.82592568 |
16 | MP0002419_abnormal_innate_immunity | 2.73720232 |
17 | MP0001790_abnormal_immune_system | 2.70258671 |
18 | MP0005387_immune_system_phenotype | 2.70258671 |
19 | MP0000751_myopathy | 2.67576043 |
20 | MP0005330_cardiomyopathy | 2.62902799 |
21 | MP0005365_abnormal_bile_salt | 2.60227170 |
22 | MP0009785_altered_susceptibility_to | 2.59346062 |
23 | MP0005671_abnormal_response_to | 2.59039006 |
24 | MP0005025_abnormal_response_to | 2.55444284 |
25 | MP0002148_abnormal_hypersensitivity_rea | 2.44092399 |
26 | MP0003300_gastrointestinal_ulcer | 2.43834084 |
27 | MP0005000_abnormal_immune_tolerance | 2.39850873 |
28 | MP0004036_abnormal_muscle_relaxation | 2.35302986 |
29 | MP0004264_abnormal_extraembryonic_tissu | 2.30398795 |
30 | MP0010234_abnormal_vibrissa_follicle | 2.29084439 |
31 | MP0004484_altered_response_of | 2.28565088 |
32 | MP0001800_abnormal_humoral_immune | 2.28289543 |
33 | MP0002139_abnormal_hepatobiliary_system | 2.26907512 |
34 | MP0009840_abnormal_foam_cell | 2.25662612 |
35 | MP0000462_abnormal_digestive_system | 2.24628832 |
36 | MP0002972_abnormal_cardiac_muscle | 2.21948275 |
37 | MP0000685_abnormal_immune_system | 2.18632694 |
38 | MP0002452_abnormal_antigen_presenting | 2.14131300 |
39 | MP0001873_stomach_inflammation | 2.11161708 |
40 | MP0003172_abnormal_lysosome_physiology | 2.09703421 |
41 | MP0003191_abnormal_cellular_cholesterol | 2.08993772 |
42 | MP0001533_abnormal_skeleton_physiology | 2.08628134 |
43 | MP0002723_abnormal_immune_serum | 2.08586176 |
44 | MP0005084_abnormal_gallbladder_morpholo | 2.01081681 |
45 | MP0003252_abnormal_bile_duct | 1.99382186 |
46 | MP0009379_abnormal_foot_pigmentation | 1.96145742 |
47 | MP0002420_abnormal_adaptive_immunity | 1.95308930 |
48 | MP0001819_abnormal_immune_cell | 1.94695697 |
49 | MP0008775_abnormal_heart_ventricle | 1.93970776 |
50 | MP0003828_pulmonary_edema | 1.89107640 |
51 | MP0004947_skin_inflammation | 1.87688086 |
52 | MP0006138_congestive_heart_failure | 1.86681851 |
53 | MP0010630_abnormal_cardiac_muscle | 1.80998345 |
54 | MP0004087_abnormal_muscle_fiber | 1.80976430 |
55 | MP0001544_abnormal_cardiovascular_syste | 1.76699411 |
56 | MP0005385_cardiovascular_system_phenoty | 1.76699411 |
57 | MP0005220_abnormal_exocrine_pancreas | 1.72466989 |
58 | MP0003075_altered_response_to | 1.70743929 |
59 | MP0001845_abnormal_inflammatory_respons | 1.70722617 |
60 | MP0001663_abnormal_digestive_system | 1.69691319 |
61 | MP0010368_abnormal_lymphatic_system | 1.67609482 |
62 | MP0005620_abnormal_muscle_contractility | 1.67279760 |
63 | MP0002405_respiratory_system_inflammati | 1.66913436 |
64 | MP0002998_abnormal_bone_remodeling | 1.64634701 |
65 | MP0004043_abnormal_pH_regulation | 1.64548630 |
66 | MP0003183_abnormal_peptide_metabolism | 1.62412066 |
67 | MP0000749_muscle_degeneration | 1.61108562 |
68 | MP0009278_abnormal_bone_marrow | 1.60697714 |
69 | MP0005166_decreased_susceptibility_to | 1.58226709 |
70 | MP0005464_abnormal_platelet_physiology | 1.57782884 |
71 | MP0005381_digestive/alimentary_phenotyp | 1.52840859 |
72 | MP0006036_abnormal_mitochondrial_physio | 1.51561426 |
73 | MP0005310_abnormal_salivary_gland | 1.51183297 |
74 | MP0009643_abnormal_urine_homeostasis | 1.50954939 |
75 | MP0005165_increased_susceptibility_to | 1.49485677 |
76 | MP0000750_abnormal_muscle_regeneration | 1.49482464 |
77 | MP0000343_altered_response_to | 1.49443450 |
78 | * MP0003137_abnormal_impulse_conducting | 1.49144212 |
79 | MP0003868_abnormal_feces_composition | 1.48534339 |
80 | MP0008469_abnormal_protein_level | 1.48415269 |
81 | MP0000465_gastrointestinal_hemorrhage | 1.47484449 |
82 | MP0009764_decreased_sensitivity_to | 1.44379176 |
83 | MP0009333_abnormal_splenocyte_physiolog | 1.42644330 |
84 | MP0003763_abnormal_thymus_physiology | 1.41905799 |
85 | * MP0001664_abnormal_digestion | 1.40114723 |
86 | MP0003806_abnormal_nucleotide_metabolis | 1.39758066 |
87 | MP0000716_abnormal_immune_system | 1.39406954 |
88 | MP0006054_spinal_hemorrhage | 1.39009394 |
89 | MP0008260_abnormal_autophagy | 1.37004955 |
90 | MP0010155_abnormal_intestine_physiology | 1.35269260 |
91 | MP0000604_amyloidosis | 1.33877096 |
92 | MP0003705_abnormal_hypodermis_morpholog | 1.31028964 |
93 | MP0004130_abnormal_muscle_cell | 1.30366959 |
94 | MP0000537_abnormal_urethra_morphology | 1.29439173 |
95 | MP0000490_abnormal_crypts_of | 1.27438186 |
96 | MP0002132_abnormal_respiratory_system | 1.23171750 |
97 | MP0000858_altered_metastatic_potential | 1.22871562 |
98 | MP0002398_abnormal_bone_marrow | 1.22136795 |
99 | MP0004085_abnormal_heartbeat | 1.21982055 |
100 | MP0003866_abnormal_defecation | 1.21077887 |
101 | MP0005451_abnormal_body_composition | 1.19200458 |
102 | MP0005332_abnormal_amino_acid | 1.18222175 |
103 | MP0001765_abnormal_ion_homeostasis | 1.16869456 |
104 | MP0003690_abnormal_glial_cell | 1.16336844 |
105 | MP0003221_abnormal_cardiomyocyte_apopto | 1.16061764 |
106 | MP0001853_heart_inflammation | 1.15362098 |
107 | MP0002127_abnormal_cardiovascular_syste | 1.14914336 |
108 | MP0002254_reproductive_system_inflammat | 1.14448430 |
109 | MP0001545_abnormal_hematopoietic_system | 1.11971105 |
110 | MP0005397_hematopoietic_system_phenotyp | 1.11971105 |
111 | MP0001851_eye_inflammation | 1.10039917 |
112 | MP0008875_abnormal_xenobiotic_pharmacok | 1.09349335 |
113 | MP0002928_abnormal_bile_duct | 1.08282399 |
114 | MP0000689_abnormal_spleen_morphology | 1.06826390 |
115 | MP0004233_abnormal_muscle_weight | 1.06485745 |
116 | MP0002429_abnormal_blood_cell | 1.06418106 |
117 | MP0003950_abnormal_plasma_membrane | 1.05601700 |
118 | MP0003453_abnormal_keratinocyte_physiol | 1.04972140 |
119 | MP0004883_abnormal_blood_vessel | 1.04839766 |
120 | MP0001879_abnormal_lymphatic_vessel | 1.04721048 |
121 | MP0003448_altered_tumor_morphology | 1.04607282 |
122 | MP0002722_abnormal_immune_system | 1.04591872 |
123 | MP0004272_abnormal_basement_membrane | 1.03203675 |
124 | * MP0008004_abnormal_stomach_pH | 1.01621112 |
125 | MP0004019_abnormal_vitamin_homeostasis | 1.00170953 |
126 | MP0002106_abnormal_muscle_physiology | 0.99917675 |
127 | MP0005167_abnormal_blood-brain_barrier | 0.96897069 |
128 | MP0009384_cardiac_valve_regurgitation | 0.95813695 |
129 | MP0005666_abnormal_adipose_tissue | 0.93865640 |
130 | MP0005164_abnormal_response_to | 0.93391008 |
131 | MP0003567_abnormal_fetal_cardiomyocyte | 0.91759612 |
132 | MP0005319_abnormal_enzyme/_coenzyme | 0.91311777 |
133 | MP0002269_muscular_atrophy | 0.90737986 |
134 | MP0001756_abnormal_urination | 0.90668004 |
135 | MP0002277_abnormal_respiratory_mucosa | 0.89745298 |
136 | MP0000566_synostosis | 0.89102304 |
137 | MP0005390_skeleton_phenotype | 0.88422189 |
138 | MP0000230_abnormal_systemic_arterial | 0.88339219 |
139 | MP0000249_abnormal_blood_vessel | 0.87910293 |
140 | MP0000538_abnormal_urinary_bladder | 0.87732311 |
141 | MP0003879_abnormal_hair_cell | 0.87515339 |
142 | MP0010329_abnormal_lipoprotein_level | 0.82945044 |
143 | MP0004782_abnormal_surfactant_physiolog | 0.82696612 |
144 | MP0003091_abnormal_cell_migration | 0.82493008 |
145 | MP0000681_abnormal_thyroid_gland | 0.80271556 |
146 | MP0000613_abnormal_salivary_gland | 0.78932316 |
147 | MP0005076_abnormal_cell_differentiation | 0.78923913 |
148 | MP0002118_abnormal_lipid_homeostasis | 0.77895505 |
149 | MP0004510_myositis | 0.77777965 |
150 | MP0003123_paternal_imprinting | 0.77644233 |
151 | MP0000477_abnormal_intestine_morphology | 0.77314061 |
152 | MP0005636_abnormal_mineral_homeostasis | 0.77236113 |
153 | MP0009763_increased_sensitivity_to | 0.77223312 |
154 | MP0003566_abnormal_cell_adhesion | 0.73797946 |
155 | MP0002933_joint_inflammation | 0.73740383 |
156 | MP0003045_fibrosis | 0.73716467 |
157 | MP0005369_muscle_phenotype | 0.73475274 |
158 | MP0003329_amyloid_beta_deposits | 0.73282782 |
159 | MP0002166_altered_tumor_susceptibility | 0.72801285 |
160 | MP0004185_abnormal_adipocyte_glucose | 0.72771402 |
161 | * MP0000266_abnormal_heart_morphology | 0.71223015 |
162 | MP0003795_abnormal_bone_structure | 0.70830567 |
163 | MP0003283_abnormal_digestive_organ | 0.70692502 |
164 | MP0002098_abnormal_vibrissa_morphology | 0.69999297 |
165 | MP0002693_abnormal_pancreas_physiology | 0.69589555 |
166 | MP0000703_abnormal_thymus_morphology | 0.68223286 |
167 | MP0010352_gastrointestinal_tract_polyps | 0.65630626 |
168 | MP0004147_increased_porphyrin_level | 0.65389415 |
169 | MP0002234_abnormal_pharynx_morphology | 0.65304069 |
170 | MP0005375_adipose_tissue_phenotype | 0.64643761 |
171 | MP0001849_ear_inflammation | 0.64557330 |
172 | MP0002136_abnormal_kidney_physiology | 0.63038725 |
173 | MP0004858_abnormal_nervous_system | 0.62624050 |
174 | MP0000003_abnormal_adipose_tissue | 0.61390924 |
175 | * MP0000470_abnormal_stomach_morphology | 0.60744817 |
176 | MP0008874_decreased_physiological_sensi | 0.60739194 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Right ventricular cardiomyopathy (HP:0011663) | 6.25820795 |
2 | Eczematoid dermatitis (HP:0000976) | 5.64550331 |
3 | Sudden death (HP:0001699) | 5.44444991 |
4 | Ventricular tachycardia (HP:0004756) | 5.30659702 |
5 | Abnormality of macrophages (HP:0004311) | 5.08134664 |
6 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.94015039 |
7 | * Ventricular fibrillation (HP:0001663) | 4.83129994 |
8 | Recurrent abscess formation (HP:0002722) | 4.75202763 |
9 | Recurrent bacterial skin infections (HP:0005406) | 4.67982584 |
10 | Systemic lupus erythematosus (HP:0002725) | 4.57289539 |
11 | Ileus (HP:0002595) | 4.47219866 |
12 | Palpitations (HP:0001962) | 4.45014183 |
13 | Myositis (HP:0100614) | 4.40805502 |
14 | Orchitis (HP:0100796) | 4.31132066 |
15 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.23152175 |
16 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.23152175 |
17 | Abnormality of glycolipid metabolism (HP:0010969) | 4.23152175 |
18 | * Syncope (HP:0001279) | 4.13183728 |
19 | Optic neuritis (HP:0100653) | 3.94738867 |
20 | Retrobulbar optic neuritis (HP:0100654) | 3.94738867 |
21 | Lipoatrophy (HP:0100578) | 3.77279370 |
22 | Hepatic necrosis (HP:0002605) | 3.75657188 |
23 | Ketoacidosis (HP:0001993) | 3.74260713 |
24 | Increased cerebral lipofuscin (HP:0011813) | 3.71473318 |
25 | Stomatitis (HP:0010280) | 3.61394175 |
26 | * Ventricular arrhythmia (HP:0004308) | 3.61331651 |
27 | Bundle branch block (HP:0011710) | 3.56896163 |
28 | * Atrial fibrillation (HP:0005110) | 3.51985561 |
29 | Vacuolated lymphocytes (HP:0001922) | 3.49999423 |
30 | Gout (HP:0001997) | 3.44348564 |
31 | Mediastinal lymphadenopathy (HP:0100721) | 3.41711678 |
32 | Dilated cardiomyopathy (HP:0001644) | 3.40067074 |
33 | Hypoglycemic coma (HP:0001325) | 3.37166047 |
34 | Dysostosis multiplex (HP:0000943) | 3.37048469 |
35 | Increased muscle lipid content (HP:0009058) | 3.36092656 |
36 | Myoglobinuria (HP:0002913) | 3.34438284 |
37 | * Prolonged QT interval (HP:0001657) | 3.33919308 |
38 | Hepatocellular necrosis (HP:0001404) | 3.32866455 |
39 | Spontaneous hematomas (HP:0007420) | 3.32805071 |
40 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.30174900 |
41 | Muscle fiber splitting (HP:0003555) | 3.26180858 |
42 | * Primary atrial arrhythmia (HP:0001692) | 3.21589497 |
43 | Loss of speech (HP:0002371) | 3.20293325 |
44 | Gingivitis (HP:0000230) | 3.19852300 |
45 | Rectal prolapse (HP:0002035) | 3.17543336 |
46 | * Supraventricular tachycardia (HP:0004755) | 3.12470303 |
47 | Increased intramyocellular lipid droplets (HP:0012240) | 3.09845026 |
48 | * Supraventricular arrhythmia (HP:0005115) | 3.09565694 |
49 | Glomerulonephritis (HP:0000099) | 3.08851065 |
50 | Decreased circulating renin level (HP:0003351) | 3.03537188 |
51 | Chronic obstructive pulmonary disease (HP:0006510) | 3.01532290 |
52 | Obstructive lung disease (HP:0006536) | 3.01532290 |
53 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.00786097 |
54 | Calf muscle hypertrophy (HP:0008981) | 2.98710285 |
55 | Amyloidosis (HP:0011034) | 2.97660174 |
56 | Recurrent fungal infections (HP:0002841) | 2.97230760 |
57 | Keratoconjunctivitis sicca (HP:0001097) | 2.95284127 |
58 | Glycosuria (HP:0003076) | 2.92409704 |
59 | Abnormality of urine glucose concentration (HP:0011016) | 2.92409704 |
60 | Meningitis (HP:0001287) | 2.89933538 |
61 | Dicarboxylic aciduria (HP:0003215) | 2.89718041 |
62 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.89718041 |
63 | Recurrent skin infections (HP:0001581) | 2.88363640 |
64 | Mitochondrial inheritance (HP:0001427) | 2.86368491 |
65 | Complement deficiency (HP:0004431) | 2.86182653 |
66 | Hyperammonemia (HP:0001987) | 2.83679937 |
67 | Acute encephalopathy (HP:0006846) | 2.81443774 |
68 | Ketosis (HP:0001946) | 2.81370751 |
69 | Exercise-induced myalgia (HP:0003738) | 2.80914855 |
70 | Vasculitis (HP:0002633) | 2.79839401 |
71 | * Abnormal EKG (HP:0003115) | 2.78201076 |
72 | Abnormality of chloride homeostasis (HP:0011422) | 2.76974248 |
73 | Conjunctival hamartoma (HP:0100780) | 2.75142222 |
74 | Hyperglycinuria (HP:0003108) | 2.72104582 |
75 | Gastrointestinal infarctions (HP:0005244) | 2.71486787 |
76 | Increased IgE level (HP:0003212) | 2.70843621 |
77 | Lipid accumulation in hepatocytes (HP:0006561) | 2.70532544 |
78 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.65718421 |
79 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.65665424 |
80 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.65665424 |
81 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.65665424 |
82 | Abnormal hemoglobin (HP:0011902) | 2.65634484 |
83 | Abnormality of complement system (HP:0005339) | 2.65520923 |
84 | Keratoconjunctivitis (HP:0001096) | 2.65046136 |
85 | Purpura (HP:0000979) | 2.64249595 |
86 | Heart block (HP:0012722) | 2.63713372 |
87 | Abnormality of the calf musculature (HP:0001430) | 2.62579222 |
88 | Exercise-induced muscle cramps (HP:0003710) | 2.61714145 |
89 | Increased CSF lactate (HP:0002490) | 2.59671737 |
90 | Pulmonary infiltrates (HP:0002113) | 2.59513274 |
91 | Disinhibition (HP:0000734) | 2.59438219 |
92 | Hemoptysis (HP:0002105) | 2.58434309 |
93 | Urticaria (HP:0001025) | 2.57711657 |
94 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.57083461 |
95 | Mucopolysacchariduria (HP:0008155) | 2.56402621 |
96 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.56402621 |
97 | Increased purine levels (HP:0004368) | 2.56302900 |
98 | Hyperuricemia (HP:0002149) | 2.56302900 |
99 | Rhabdomyolysis (HP:0003201) | 2.55648765 |
100 | Late onset (HP:0003584) | 2.54654605 |
101 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.53950057 |
102 | Proximal tubulopathy (HP:0000114) | 2.52232693 |
103 | Asymmetric septal hypertrophy (HP:0001670) | 2.51578604 |
104 | Encephalitis (HP:0002383) | 2.49723140 |
105 | Cellulitis (HP:0100658) | 2.47751971 |
106 | Abnormal atrioventricular conduction (HP:0005150) | 2.47263099 |
107 | Generalized aminoaciduria (HP:0002909) | 2.46204135 |
108 | Acute necrotizing encephalopathy (HP:0006965) | 2.45766783 |
109 | Inflammation of the large intestine (HP:0002037) | 2.44619884 |
110 | Petechiae (HP:0000967) | 2.44351406 |
111 | Subaortic stenosis (HP:0001682) | 2.41706363 |
112 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.41706363 |
113 | Thin bony cortex (HP:0002753) | 2.41440914 |
114 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.37558352 |
115 | Colitis (HP:0002583) | 2.37537642 |
116 | Axonal loss (HP:0003447) | 2.35901826 |
117 | Gastrointestinal inflammation (HP:0004386) | 2.35311053 |
118 | Abnormal pancreas size (HP:0012094) | 2.33798578 |
119 | Increased hepatocellular lipid droplets (HP:0006565) | 2.33643411 |
120 | Cerebral edema (HP:0002181) | 2.32054995 |
121 | Lactic acidosis (HP:0003128) | 2.31535659 |
122 | Increased connective tissue (HP:0009025) | 2.30706262 |
123 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.29302685 |
124 | Recurrent cutaneous fungal infections (HP:0011370) | 2.29302685 |
125 | Hematochezia (HP:0002573) | 2.28707933 |
126 | Hyperactive renin-angiotensin system (HP:0000841) | 2.28621458 |
127 | Hyporeflexia of lower limbs (HP:0002600) | 2.28497147 |
128 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.27416552 |
129 | Abnormality of alanine metabolism (HP:0010916) | 2.27416552 |
130 | Hyperalaninemia (HP:0003348) | 2.27416552 |
131 | Respiratory failure (HP:0002878) | 2.22032801 |
132 | Interstitial pulmonary disease (HP:0006530) | 2.21377444 |
133 | Autoimmune thrombocytopenia (HP:0001973) | 2.20799269 |
134 | Pustule (HP:0200039) | 2.20788663 |
135 | Prolonged bleeding time (HP:0003010) | 2.20526464 |
136 | Biliary tract neoplasm (HP:0100574) | 2.20519443 |
137 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.20381472 |
138 | Recurrent viral infections (HP:0004429) | 2.19977441 |
139 | Palmoplantar keratoderma (HP:0000982) | 2.18971438 |
140 | Neoplasm of the rectum (HP:0100743) | 2.18277103 |
141 | Abnormality of the nasal mucosa (HP:0000433) | 2.17572953 |
142 | Chest pain (HP:0100749) | 2.16642202 |
143 | Abnormal biliary tract morphology (HP:0012440) | 2.16426133 |
144 | Abnormality of purine metabolism (HP:0004352) | 2.15959004 |
145 | Lethargy (HP:0001254) | 2.15921662 |
146 | Atrioventricular block (HP:0001678) | 2.15544568 |
147 | Pulmonary embolism (HP:0002204) | 2.13951270 |
148 | Progressive macrocephaly (HP:0004481) | 2.12422177 |
149 | Metabolic acidosis (HP:0001942) | 2.11352464 |
150 | Abnormality of glycine metabolism (HP:0010895) | 2.11327760 |
151 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.11327760 |
152 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.09938332 |
153 | Osteomyelitis (HP:0002754) | 2.06712480 |
154 | Neonatal death (HP:0003811) | 2.06080523 |
155 | Arterial thrombosis (HP:0004420) | 2.05914739 |
156 | Esophageal varix (HP:0002040) | 2.05858026 |
157 | Ragged-red muscle fibers (HP:0003200) | 2.05779913 |
158 | Episodic fever (HP:0001954) | 2.05356516 |
159 | Nephritis (HP:0000123) | 2.05137242 |
160 | Abnormality of vitamin B metabolism (HP:0004340) | 2.04115833 |
161 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.03375732 |
162 | Hemorrhage of the eye (HP:0011885) | 2.02277742 |
163 | Fragile skin (HP:0001030) | 2.02127639 |
164 | Increased serum ferritin (HP:0003281) | 2.01751794 |
165 | Neoplasm of the small intestine (HP:0100833) | 2.01086319 |
166 | Hepatosplenomegaly (HP:0001433) | 2.00758492 |
167 | Increased serum lactate (HP:0002151) | 2.00356418 |
168 | Nausea (HP:0002018) | 1.98096718 |
169 | Epistaxis (HP:0000421) | 1.97976912 |
170 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.97417671 |
171 | Vertigo (HP:0002321) | 1.96850903 |
172 | Premature loss of primary teeth (HP:0006323) | 1.96745060 |
173 | Gingival bleeding (HP:0000225) | 1.96422325 |
174 | Leukocytosis (HP:0001974) | 1.95223822 |
175 | Exercise intolerance (HP:0003546) | 1.94316513 |
176 | Acne (HP:0001061) | 1.94044158 |
177 | Increased IgM level (HP:0003496) | 1.93825827 |
178 | Mutism (HP:0002300) | 1.93273755 |
179 | Dehydration (HP:0001944) | 1.92755162 |
180 | Nasal polyposis (HP:0100582) | 1.92694976 |
181 | Gastrointestinal stroma tumor (HP:0100723) | 1.92557097 |
182 | Restrictive lung disease (HP:0002091) | 1.92153605 |
183 | Polyneuropathy (HP:0001271) | 1.91659335 |
184 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.91294622 |
185 | Cavernous hemangioma (HP:0001048) | 1.90694013 |
186 | Malnutrition (HP:0004395) | 1.89951487 |
187 | Abnormality of iron homeostasis (HP:0011031) | 1.89539673 |
188 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.88726485 |
189 | Abnormality of the pleura (HP:0002103) | 1.87140860 |
190 | Male infertility (HP:0003251) | 1.86828252 |
191 | T lymphocytopenia (HP:0005403) | 1.83337079 |
192 | Neurofibrillary tangles (HP:0002185) | 1.81145416 |
193 | Neuronal loss in central nervous system (HP:0002529) | 1.80715147 |
194 | Myocardial infarction (HP:0001658) | 1.79810792 |
195 | Hypergammaglobulinemia (HP:0010702) | 1.79031296 |
196 | Anorexia (HP:0002039) | 1.77486675 |
197 | Pathologic fracture (HP:0002756) | 1.76852314 |
198 | Abnormality of T cell number (HP:0011839) | 1.76390163 |
Rank | Gene Set | Z-score |
---|---|---|
1 | LMTK2 | 7.37415368 |
2 | RIPK4 | 3.70839887 |
3 | FRK | 3.43608909 |
4 | BCKDK | 3.10486596 |
5 | PRPF4B | 3.04649955 |
6 | BLK | 3.01485911 |
7 | MAP4K1 | 2.97705426 |
8 | WNK4 | 2.88020080 |
9 | PKN2 | 2.86529784 |
10 | MYLK | 2.78924102 |
11 | TIE1 | 2.73617489 |
12 | TYK2 | 2.61227771 |
13 | TTN | 2.45239204 |
14 | STK39 | 2.29718825 |
15 | IRAK4 | 2.28749569 |
16 | MAP2K3 | 2.22446501 |
17 | CSK | 2.20998238 |
18 | PRKG2 | 2.10096502 |
19 | PDK3 | 2.07945800 |
20 | PDK4 | 2.07945800 |
21 | RIPK1 | 2.06990954 |
22 | MST1R | 1.98424859 |
23 | STK38L | 1.96898882 |
24 | TRIB3 | 1.96646434 |
25 | MAP2K2 | 1.93962663 |
26 | ZAP70 | 1.93880656 |
27 | TAOK3 | 1.93253056 |
28 | MAP3K14 | 1.87758312 |
29 | DMPK | 1.84247738 |
30 | NUAK1 | 1.75630434 |
31 | FES | 1.73903207 |
32 | NME1 | 1.72460142 |
33 | PIK3CA | 1.71021918 |
34 | LATS1 | 1.70624439 |
35 | TAOK2 | 1.59012970 |
36 | EPHB2 | 1.53590950 |
37 | FGR | 1.52895101 |
38 | MAP2K6 | 1.51277032 |
39 | PDK2 | 1.48816192 |
40 | PHKG1 | 1.47889764 |
41 | PHKG2 | 1.47889764 |
42 | TNK2 | 1.47221707 |
43 | KDR | 1.44927281 |
44 | PTK6 | 1.40481262 |
45 | MAP3K13 | 1.39003931 |
46 | IKBKE | 1.38371692 |
47 | JAK3 | 1.38214297 |
48 | JAK1 | 1.37544554 |
49 | SIK1 | 1.35473291 |
50 | BTK | 1.32530215 |
51 | CSF1R | 1.26289734 |
52 | MATK | 1.25202736 |
53 | HCK | 1.24297287 |
54 | SYK | 1.22305633 |
55 | GRK6 | 1.22103324 |
56 | JAK2 | 1.17501875 |
57 | OBSCN | 1.16550783 |
58 | EPHA2 | 1.13491347 |
59 | TXK | 1.12714695 |
60 | DDR2 | 1.11357804 |
61 | ERN1 | 1.06366283 |
62 | NEK1 | 1.05874523 |
63 | LYN | 1.03189683 |
64 | STK24 | 1.02990881 |
65 | IKBKB | 1.02481708 |
66 | IRAK1 | 1.02449781 |
67 | MST4 | 1.01636672 |
68 | IRAK3 | 0.99302527 |
69 | PDK1 | 0.96852361 |
70 | TGFBR2 | 0.96430124 |
71 | MARK2 | 0.96235809 |
72 | IRAK2 | 0.95632226 |
73 | MAP3K11 | 0.95497090 |
74 | MAP3K5 | 0.94819061 |
75 | OXSR1 | 0.94201185 |
76 | LCK | 0.88069068 |
77 | PBK | 0.88018612 |
78 | PRKAA2 | 0.87251609 |
79 | ACVR1B | 0.84569377 |
80 | AKT3 | 0.82593965 |
81 | SIK3 | 0.81911370 |
82 | MAP3K3 | 0.81558419 |
83 | MAPK12 | 0.81248058 |
84 | MARK3 | 0.81036803 |
85 | ITK | 0.81002755 |
86 | PAK3 | 0.80701333 |
87 | SMG1 | 0.80398472 |
88 | EPHA3 | 0.80100422 |
89 | ICK | 0.79851210 |
90 | NME2 | 0.78809099 |
91 | PRKD2 | 0.78506753 |
92 | ERBB2 | 0.78307490 |
93 | KSR2 | 0.78281878 |
94 | MAPK7 | 0.77420320 |
95 | TTK | 0.75910834 |
96 | CAMK2D | 0.73569020 |
97 | BMPR2 | 0.73473355 |
98 | ILK | 0.72868377 |
99 | MAPK15 | 0.72534012 |
100 | KIT | 0.72233771 |
101 | INSRR | 0.68580134 |
102 | ROCK1 | 0.68498654 |
103 | PRKAA1 | 0.68056778 |
104 | PRKD1 | 0.67035683 |
105 | RPS6KL1 | 0.66128854 |
106 | RPS6KC1 | 0.66128854 |
107 | TESK2 | 0.65250574 |
108 | PTK2 | 0.64548879 |
109 | STK4 | 0.62655984 |
110 | YES1 | 0.62152398 |
111 | MUSK | 0.61845728 |
112 | CDC42BPA | 0.61747428 |
113 | FER | 0.61605766 |
114 | NEK9 | 0.60590293 |
115 | HIPK2 | 0.59108282 |
116 | MAP2K1 | 0.58976981 |
117 | PAK4 | 0.58767406 |
118 | STK10 | 0.58688917 |
119 | MET | 0.58424345 |
120 | LRRK2 | 0.58197130 |
121 | MAP3K6 | 0.57149994 |
122 | MAPKAPK3 | 0.56718065 |
123 | MAP3K7 | 0.54492564 |
124 | GRK1 | 0.54411793 |
125 | CAMK1D | 0.53082092 |
126 | RPS6KA6 | 0.52476248 |
127 | NLK | 0.52404536 |
128 | RPS6KA2 | 0.52038975 |
129 | FYN | 0.50824863 |
130 | CHUK | 0.49273342 |
131 | AURKB | 0.48963013 |
132 | WNK1 | 0.48090611 |
133 | FGFR3 | 0.47730401 |
134 | TRPM7 | 0.47395179 |
135 | STK38 | 0.47270136 |
136 | DYRK1B | 0.47189293 |
137 | TEC | 0.47066588 |
138 | FLT3 | 0.46481591 |
139 | PDGFRA | 0.46124649 |
140 | TGFBR1 | 0.45605203 |
141 | MELK | 0.45565055 |
142 | MAP3K2 | 0.45455249 |
143 | CAMKK2 | 0.45209294 |
144 | SGK3 | 0.44807087 |
145 | PIM1 | 0.44395940 |
146 | EPHB1 | 0.43507880 |
147 | PINK1 | 0.42752419 |
148 | MAP3K1 | 0.40485566 |
149 | RET | 0.40207631 |
150 | MAPK11 | 0.39358423 |
151 | MOS | 0.39180912 |
152 | RPS6KB2 | 0.39091698 |
153 | MAPK4 | 0.38742577 |
154 | FGFR4 | 0.38021890 |
155 | MAP3K10 | 0.37519528 |
156 | GRK7 | 0.36121046 |
157 | TBK1 | 0.36104135 |
158 | PRKD3 | 0.29224316 |
159 | DAPK2 | 0.28109906 |
160 | EIF2AK1 | 0.27396363 |
161 | STK3 | 0.26946206 |
162 | PDPK1 | 0.26404078 |
163 | PRKACB | 0.26150556 |
164 | CAMK2G | 0.26003678 |
165 | PDGFRB | 0.25855790 |
166 | PRKCI | 0.24096815 |
167 | PRKACG | 0.23971162 |
168 | CAMK4 | 0.23954281 |
169 | MAP3K8 | 0.22206382 |
170 | EEF2K | 0.21652052 |
171 | RPS6KA1 | 0.19613555 |
172 | PIK3CG | 0.19158700 |
173 | TAOK1 | 0.19082183 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 4.36685420 |
2 | Fat digestion and absorption_Homo sapiens_hsa04975 | 3.21008173 |
3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.11476925 |
4 | Fatty acid degradation_Homo sapiens_hsa00071 | 3.11003100 |
5 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.02514469 |
6 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.93874458 |
7 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.88522399 |
8 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.75242136 |
9 | Leishmaniasis_Homo sapiens_hsa05140 | 2.70075260 |
10 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.68641257 |
11 | Parkinsons disease_Homo sapiens_hsa05012 | 2.66244256 |
12 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.63402136 |
13 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.50002103 |
14 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.43485038 |
15 | Allograft rejection_Homo sapiens_hsa05330 | 2.41818917 |
16 | * Pancreatic secretion_Homo sapiens_hsa04972 | 2.36698965 |
17 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.26710210 |
18 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.14282985 |
19 | * Protein digestion and absorption_Homo sapiens_hsa04974 | 2.05286549 |
20 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.04109643 |
21 | Carbon metabolism_Homo sapiens_hsa01200 | 2.03474970 |
22 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.01704511 |
23 | Alzheimers disease_Homo sapiens_hsa05010 | 2.00428452 |
24 | Tuberculosis_Homo sapiens_hsa05152 | 1.98293354 |
25 | Asthma_Homo sapiens_hsa05310 | 1.93686634 |
26 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.90830797 |
27 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.89880283 |
28 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.86553440 |
29 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.79698061 |
30 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.79447560 |
31 | Lysosome_Homo sapiens_hsa04142 | 1.70642627 |
32 | Huntingtons disease_Homo sapiens_hsa05016 | 1.70306863 |
33 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.67047472 |
34 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.67008644 |
35 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.65905771 |
36 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.64738199 |
37 | Malaria_Homo sapiens_hsa05144 | 1.61913106 |
38 | Pertussis_Homo sapiens_hsa05133 | 1.60846352 |
39 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.59169987 |
40 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.56636169 |
41 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.54817147 |
42 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.54560792 |
43 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.50563484 |
44 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.49737499 |
45 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.48480055 |
46 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.47498852 |
47 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.47057596 |
48 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.46134454 |
49 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.45967932 |
50 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.44907231 |
51 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.44863562 |
52 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.44232204 |
53 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.41954048 |
54 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.41910922 |
55 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.41332312 |
56 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.40056968 |
57 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.39484989 |
58 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.37120411 |
59 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.37017715 |
60 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.34776234 |
61 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.34385633 |
62 | Phagosome_Homo sapiens_hsa04145 | 1.31086602 |
63 | Legionellosis_Homo sapiens_hsa05134 | 1.29053470 |
64 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.27925314 |
65 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.27143867 |
66 | Histidine metabolism_Homo sapiens_hsa00340 | 1.26338340 |
67 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.26288464 |
68 | Mineral absorption_Homo sapiens_hsa04978 | 1.25219417 |
69 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.24914449 |
70 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.24436710 |
71 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.23863060 |
72 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.15877179 |
73 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.11924807 |
74 | Bile secretion_Homo sapiens_hsa04976 | 1.11448874 |
75 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.10733696 |
76 | Salmonella infection_Homo sapiens_hsa05132 | 1.09921277 |
77 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.09915638 |
78 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.08988323 |
79 | Measles_Homo sapiens_hsa05162 | 1.07815056 |
80 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.07582179 |
81 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.07551604 |
82 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.07343434 |
83 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.05602900 |
84 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.05180346 |
85 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.00015824 |
86 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.98728003 |
87 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.95612491 |
88 | Ribosome_Homo sapiens_hsa03010 | 0.95476833 |
89 | Lysine degradation_Homo sapiens_hsa00310 | 0.94382348 |
90 | Tight junction_Homo sapiens_hsa04530 | 0.93213258 |
91 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.88889515 |
92 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.88245158 |
93 | Amoebiasis_Homo sapiens_hsa05146 | 0.87507853 |
94 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.86511381 |
95 | Galactose metabolism_Homo sapiens_hsa00052 | 0.85654248 |
96 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.85413376 |
97 | Peroxisome_Homo sapiens_hsa04146 | 0.85210962 |
98 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.84380321 |
99 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.83707654 |
100 | Hepatitis B_Homo sapiens_hsa05161 | 0.82876662 |
101 | Prion diseases_Homo sapiens_hsa05020 | 0.81053386 |
102 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.79132627 |
103 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.78948092 |
104 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.78926825 |
105 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.78525764 |
106 | Apoptosis_Homo sapiens_hsa04210 | 0.78086940 |
107 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.77610238 |
108 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.76656387 |
109 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.75353729 |
110 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.74483910 |
111 | Platelet activation_Homo sapiens_hsa04611 | 0.73898413 |
112 | Other glycan degradation_Homo sapiens_hsa00511 | 0.71130650 |
113 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.70633605 |
114 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.70481197 |
115 | Shigellosis_Homo sapiens_hsa05131 | 0.66676030 |
116 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.66473498 |
117 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.65525717 |
118 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.65366891 |
119 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.61753509 |
120 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.60375320 |
121 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.60108921 |
122 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.59283529 |
123 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.58353546 |
124 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.57630208 |
125 | Endocytosis_Homo sapiens_hsa04144 | 0.56222268 |
126 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.55990900 |
127 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.55637662 |
128 | Viral myocarditis_Homo sapiens_hsa05416 | 0.55524355 |
129 | Metabolic pathways_Homo sapiens_hsa01100 | 0.55445687 |
130 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.54941633 |
131 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.54488364 |
132 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.54301194 |
133 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.53488447 |
134 | Adherens junction_Homo sapiens_hsa04520 | 0.53014814 |
135 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.51127685 |
136 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.50545767 |
137 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.50337983 |
138 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.49563254 |
139 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.48133260 |
140 | Insulin resistance_Homo sapiens_hsa04931 | 0.44597992 |
141 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.44451444 |
142 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.42502169 |
143 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.41092223 |
144 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.40545012 |
145 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.39960910 |
146 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.39184139 |
147 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.38560814 |
148 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.37893385 |
149 | ABC transporters_Homo sapiens_hsa02010 | 0.36510469 |
150 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.36053417 |
151 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.35522088 |
152 | Endometrial cancer_Homo sapiens_hsa05213 | 0.35187339 |
153 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.35137194 |
154 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.34457705 |
155 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.34043271 |
156 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.33626120 |
157 | HTLV-I infection_Homo sapiens_hsa05166 | 0.33605408 |
158 | Insulin secretion_Homo sapiens_hsa04911 | 0.33358356 |
159 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.32238576 |
160 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.31730852 |
161 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.30945378 |
162 | * Gastric acid secretion_Homo sapiens_hsa04971 | 0.30592846 |
163 | Bladder cancer_Homo sapiens_hsa05219 | 0.30561916 |
164 | Sulfur relay system_Homo sapiens_hsa04122 | 0.29771510 |
165 | * Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.29570652 |
166 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.29020175 |
167 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.25434276 |
168 | Retinol metabolism_Homo sapiens_hsa00830 | 0.24215812 |
169 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.22068525 |
170 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.21342933 |
171 | Focal adhesion_Homo sapiens_hsa04510 | 0.19344310 |
172 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.19048450 |
173 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.16626397 |
174 | Hepatitis C_Homo sapiens_hsa05160 | 0.14178605 |
175 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.13323708 |
176 | Protein export_Homo sapiens_hsa03060 | 0.12943410 |
177 | Influenza A_Homo sapiens_hsa05164 | 0.12483535 |
178 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.12382373 |
179 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.11700090 |
180 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.11347868 |
181 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.10363159 |